Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kB signal transduction pathways

British Journal of Pharmacology

Volumn 157, Issue 7, 2009, Pages 1232-1240

  Requena, Pilar ^a   Daddaoua, Abdelali ^a   Guadix, Emilia ^b   Zarzuelo, Antonio ^a   Suárez, María Dolores ^a   De Medina, Fermín Sánchez ^a   Martínez Augustin, Olga ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Bovine glycomacropeptide; NF kB; THP 1 cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BOVINE GLYCOMACROPEPTIDE; BOVINE SERUM ALBUMIN; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; KAPPA CASEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; LEUKEMIA CELL; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASEINS; CATTLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; HYDROLYSIS; I-KAPPA B PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 70350347700     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00195.x     Document Type: Article

References (36)

1. Aimutis WR (2004). Bioactive properties of milk proteins with particular focus on anticariogenesis. J Nutr 134: 989S-995S
2. Bal dit Sollier C, Drouet L, Pignaud G, Chevallier C, Caen J, Fiat AM et al. (1996). Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Thromb Res 81: 427-437
3. Bamias G, Cominelli F (2007). Immunopathogenesis of inflammatory bowel disease: current concepts. Curr Opin Gastroenterol 23: 365-1359
4. Baumgart DC, Sandborn WJ (2007). Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657
5. Beinke S, Ley SC (2004). Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382: 393-409
6. Brody EP (2000). Biological activities of bovine glycomacropeptide. Br J Nutr 84: S39-S46
7. Bruck WM, Kelleher SL, Gibson GR, Graverholt G, Lonnerdal BL (2006). The effects of alpha-lactalbumin and glycomacropeptide on the association of CaCo-2 cells by enteropathogenic Escherichia coli, Salmonella typhimurium and Shigella flexneri. FEMS Microbiol Lett 259: 158-162
8. Cho JH, Weaver CT (2007). The genetics of inflammatory bowel disease. Gastroenterology 133: 1327-1339
9. Clare DA, Catignani GL, Swaisgood HE (2003). Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharm Des 9: 1239-1255
10. Cross ML, Gill HS (2000). Immunomodulatory properties of milk. Br J Nutr 84 (Suppl. 1): S81-S89
11. Daddaoua A, Puerta V, Zarzuelo A, Suarez MD, Sanchez de Medina F, Martinez-Augustin O (2005). Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J Nutr 135: 1164-1170
12. Florisa R, Recio I, Berkhout B, Visser S (2003). Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharm Des 9: 1257-1275
13. Goldman AS (2000). Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective. J Nutr 130: 426S-431S
14. Halprin KM, Ohkawara A (1966). Lactate production and lactate dehy-drogenase in the human epidermis. J Invest Dermatol 47: 222-229
15. Li EW, Mine Y (2004). Immunoenhancing effects of bovine glycomac-ropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937. J Agric Food Chem 52: 2704-2708
16. Lim K, van Calcar SC, Nelson KL, Gleason ST, Ney DM (2007). Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU. Mol Genet Metab 92: 176-178
17. Lin JJ (1981). Monoclonal antibodies against myofibrillar components of rat skeletal muscle decorate the intermediate filaments of cultured cells. Proc Natl Acad Sci U S A 78: 2335-2339
18. Martinez-Augustin O, Boza JJ, Navarro J, Martinez-Valverde A, Araya M, Gil A (1997). Dietary nucleotides may influence the humoral immunity in immunocompromised children. Nutrition 13: 465-469
19. Mikkelsen TL, Bakman S, Sorensen ES, Barkholt V, Frokiaer H (2005). Sialic acid-containing milk proteins show differential immuno-modulatory activities independent of sialic acid. J Agric Food Chem 53: 7673-7680
20. Mikkelsen TL, Rasmussen E, Olsen A, Barkholt V, Frokiaer H (2006). Immunogenicity of kappa-casein and glycomacropeptide. J Dairy Sci 89: 824-830
21. Monnai M, Otani H (1997). Effect of bovine k-caseinoglycopeptide on secretion of interleukin-1 family cytokines by P388D1 cells, a line derived from mouse monocyte/macrophage. Milchwissenschaft 52: 192-196
22. Monnai M, Horimoto Y, Otani H (1998). Immunomodificatory effect of dietary bovine kappa-caseinoglycopeptide on serum antibody levels and proliferative responses of lymphocytes in mice. Milchwis-senschaft 53: 129-132 (Pubitemid 128050470)
23. Nakajima K, Tamura N, Kobayashi-Hattori K, Yoshida T, Hara-Kudo Y, Ikedo M et al. (2005). Prevention of intestinal infection by glyco-macropeptide. Biosci Biotechnol Biochem 69: 2294-2301
24. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S et al. (2007). Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561
25. Newby TJ, Stokes CR, Bourne FJ (1982). Immunological activity of milk. Vet Immunol Immunopathol 3: 67-94
26. Obermeier F, Dunger N, Strauch UG, Grunwald N, Herfarth H, Scholmerich J et al. (2003). Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol 134: 217-224
27. Otani H, Monnai M (1993). Inhibition of proliferative responses of mouse spleen lymphocytes by bovine milk k-casein digests. Food Agric Immunol 5: 219-229
28. Otani H, Horimoto Y, Monnai M (1996). Suppression of interleukin-2 receptor expression on mouse CD4+ T cells by bovine kappa-caseinoglycopeptide. Biosci Biotechnol Biochem 60: 1017-1019
29. Peyrin-Biroulet L, Chamaillard M (2007). NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 13: 135-139
30. Qualls JE, Kaplan AM, van Rooijen N, Cohen DA (2006). Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 80: 802-815
31. Requena P, Daddaoua A, Martínez-Plata E, González M, Zarzuelo A, Suárez MD et al. (2008). Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17. Br J Pharmacol 154: 825-832
32. Sainathan SK, Hanna EM, Gong Q, Bishnupuri KS, Luo Q, Colonna M et al. (2008). Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis 14: 88-99
33. Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I et al. (2006). Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 24 (Suppl. 3): 11-18
34. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Proven-zano MD et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85
35. Tobita K, Kawahara T, Otani H (2006). Bovine beta-casein (1-28), a casein phosphopeptide, enhances proliferation and IL-6 expression of mouse CD19+ cells via Toll-like receptor 4. J Agric Food Chem 54: 8013-8017
36. Zimecki M, Kruzel ML (2007). Milk-derived proteins and peptides of potential therapeutic and nutritive value. J Exp Ther Oncol 6: 89-106